share_log

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

ContraFect 已收到允许其美国专利申请 16/629,916 的通知,标题为 “血液成分增强溶解蛋白抗菌活性及其方法和用途”
Benzinga ·  2023/10/24 11:08

ContraFect Has Received A Notice Of Allowance For Its U.S. Patent Application 16/629,916 Titled "Blood Component Potentiation Of Lytic Protein Anti-bacterial Activity And Methods And Uses Thereof"

ContraFect 已收到允许其美国专利申请 16/629,916 的通知,标题为 “血液成分增强溶解蛋白抗菌活性及其方法和用途”

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发